Luspatercept showed real-world efficacy among patients with lower-risk myelodysplastic syndrome (MDS), confirming results ...

The myelodysplastic syndromes (MDS) are disorders of the haematopoietic stem cells in the bone marrow, that result in a decreased production of blood cells. MDS mainly affects patients aged 70 and ...